Organon Antagon Fertility Treatment Will Launch In Fourth Quarter
Executive Summary
Organon will launch its new fertility drug Antagon in the fourth quarter. Approved by FDA July 29, the ganirelix acetate injection is indicated for the inhibition of premature leutenizing hormone surges in women undergoing controlled ovarian hyperstimulation.